Literature DB >> 10637797

[Staining the lens capsule with trypan blue for visualizing capsulorhexis in surgery of mature cataracts].

G R Melles1, P W de Waard, J H Pameijer, W H Beekhuis.   

Abstract

BACKGROUND: A capsulorhexis may be difficult to perform in the absence of a red fundus reflex. PATIENTS AND METHODS: After application of 0.3 mL trypan blue 0.1%, a quick and homogeneous staining of the anterior lens capsule was obtained in 100 patients with a mature cataract, to visualize the capsulorhexis during a phacoemulsification procedure.
RESULTS: No adverse reactions related to the dye were observed up to 18 months after surgery.
CONCLUSION: Trypan blue staining of the anterior lens capsule may therefore be a safe technique to facilitate the performance of a capsulorhexis in the absence of a red fundus reflex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10637797     DOI: 10.1055/s-2008-1034729

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  5 in total

1.  Cystoid macular oedema with trypan blue use.

Authors:  P Gouws; M Merriman; S Goethals; P R Simcock; R J Greenwood; G Wright
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

Review 2.  [Vital dyes in vitreoretinal surgery. Current application concepts].

Authors:  C Haritoglou; S Thaler; A Kampik; F Schüttauf
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

3.  Comparison of trypan blue and Brilliant Blue G for staining of the anterior lens capsule during cataract surgery: short-term results.

Authors:  Takamitsu Nagashima; Kentaro Yuda; Takahiko Hayashi
Journal:  Int Ophthalmol       Date:  2017-11-29       Impact factor: 2.031

4.  [Staining techniques in macular surgery].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2006-11       Impact factor: 1.059

5.  Use of Brilliant Blue G in Descemet's Membrane Endothelial Keratoplasty.

Authors:  Takahiko Hayashi; Kentaro Yuda; Itaru Oyakawa; Naoko Kato
Journal:  Biomed Res Int       Date:  2017-06-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.